Drug Type Bispecific antibody |
Synonyms |
Mechanism Cytokine receptors antagonists, TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sepsis | Preclinical | US | - | |
Inflammatory Bowel Diseases | Discovery | US | - |